Biodegradable Nanoparticles for Immune Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccines for Streptococcus pneumoniae are costly and leave patients vulnerable to non-vaccine serotypes, with existing nanoparticle and liposome formulations facing issues like rapid drug release and adverse conditions due to prolonged retention in the body.
Innovation Solution
Development of nanoparticles with a biodegradable polymer substrate, such as PLGA, incorporating antigens and adjuvants like alphaGalactosylceramide, which are designed to elicit an immune response by positioning antigens both internally and externally within the nanoparticle structure, avoiding lipid bilayers and PEG modification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If stealth coatings are used to increase circulation time, then duration of action is improved, but harmful factors increase due to adverse conditions like hand/foot syndrome
Solution Approach 1:
The patent removes the stealth coating (PEGylation) from the nanoparticle surface, extracting the source of adverse effects while maintaining controlled drug delivery capability. This eliminates hand/foot syndrome and other toxicities associated with prolonged retention of PEGylated particles.
Solution Approach 2:
The patent changes the surface properties of nanoparticles by avoiding PEG modification, thereby altering the interaction with biological systems. This parameter change reduces adverse effects while maintaining adequate circulation time through alternative mechanisms.
2Ease of manufacture
If drugs are loaded on the nanoparticle surface, then ease of manufacture is improved, but harmful factors increase due to rapid burst release
Solution Approach 1:
The patent uses a simplified approach where the nanoparticle core itself serves as the drug carrier without complex surface conjugation. The PLGA core encapsulates the drug, providing controlled release without the need for elaborate surface loading techniques.
Solution Approach 2:
The patent employs a composite structure where the PLGA polymer core provides both structural integrity and controlled drug release properties. The combination of hydrophobic PLGA matrix with embedded drug molecules creates a system that releases drugs gradually through polymer degradation rather than rapid surface desorption.
Data Source
AI summary
The invention relates, in part, to nanoparticles, methods for preparing nanoparticles and methods of administering nanoparticles for immune stimulation. An immune-stimulating nanoparticle of the invention may include, at least in part, a polymer substrate comprising a biodegradable polymer and may include at least one antigen and/or at least one adjuvant.